188 related articles for article (PubMed ID: 25762645)
1. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells.
Rappa G; Green TM; Karbanová J; Corbeil D; Lorico A
Oncotarget; 2015 Apr; 6(10):7970-91. PubMed ID: 25762645
[TBL] [Abstract][Full Text] [Related]
2. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells.
Castro-Sanchez L; Soto-Guzman A; Navarro-Tito N; Martinez-Orozco R; Salazar EP
Eur J Cell Biol; 2010 Nov; 89(11):843-52. PubMed ID: 20709424
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
[TBL] [Abstract][Full Text] [Related]
4. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases.
Kischel P; Bellahcene A; Deux B; Lamour V; Dobson R; DE Pauw E; Clezardin P; Castronovo V
Anticancer Res; 2012 Dec; 32(12):5211-20. PubMed ID: 23225418
[TBL] [Abstract][Full Text] [Related]
6. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
Davies S; Jiang WG
Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
[TBL] [Abstract][Full Text] [Related]
7. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
9. Novel CD9-targeted therapies in gastric cancer.
Murayama Y; Oritani K; Tsutsui S
World J Gastroenterol; 2015 Mar; 21(11):3206-13. PubMed ID: 25805926
[TBL] [Abstract][Full Text] [Related]
10. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
[TBL] [Abstract][Full Text] [Related]
13. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells.
Ovalle S; Gutiérrez-López MD; Olmo N; Turnay J; Lizarbe MA; Majano P; Molina-Jiménez F; López-Cabrera M; Yáñez-Mó M; Sánchez-Madrid F; Cabañas C
Int J Cancer; 2007 Nov; 121(10):2140-52. PubMed ID: 17582603
[TBL] [Abstract][Full Text] [Related]
14. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
15. Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line.
Demou ZN; Awad M; McKee T; Perentes JY; Wang X; Munn LL; Jain RK; Boucher Y
Cancer Res; 2005 Jul; 65(13):5674-82. PubMed ID: 15994941
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
[TBL] [Abstract][Full Text] [Related]
17. Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.
Zielske SP; Livant DL; Lawrence TS
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):843-53. PubMed ID: 18849123
[TBL] [Abstract][Full Text] [Related]
18. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
19. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
20. Different states of integrin LFA-1 aggregation are controlled through its association with tetraspanin CD9.
Reyes R; Monjas A; Yánez-Mó M; Cardeñes B; Morlino G; Gilsanz A; Machado-Pineda Y; Lafuente E; Monk P; Sánchez-Madrid F; Cabañas C
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2464-80. PubMed ID: 26003300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
